• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE SENSOR; IMPLANTABLE GLUCOSE MONITORING SYSTEM, SENSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE SENSOR; IMPLANTABLE GLUCOSE MONITORING SYSTEM, SENSOR Back to Search Results
Model Number 101967-750
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Skin Infection (4544); Skin Inflammation/ Irritation (4545)
Event Date 01/03/2022
Event Type  Injury  
Event Description
Senseonics was made aware of an incident where patient developed infection at insertion site.At the beginning of week of (b)(6) , patient noticed that the area became harder than usual, but she did not notice any signs of redness or heat.This was treated with anti-inflammatory medication (ibuprofen) and she noticed improvement.Later she noticed that the area itched abnormally during the night.Then on (b)(6) 2022, the user noticed after removing the transmitter the area began to ooze.The incision site was open.Her physician recommended to stop wearing the transmitter.She went to see her doctor on (b)(6) 2022 and the doctor recommended to remove the sensor.
 
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.Senseonics was made aware of an incident where patient developed infection at insertion site.At the beginning of week of (b)(6) , patient noticed that the area became harder than usual, but she did not notice any signs of redness or heat.This was treated with anti-inflammatory medication (ibuprofen) and she noticed improvement.Later she noticed that the area itched abnormally during the night.Then on (b)(6) 2022, the user noticed after removing the transmitter the area began to ooze.The incision site was open.Her physician recommended to stop wearing the transmitter.She went to see her doctor on (b)(6) 2022 and the doctor recommended to remove the sensor.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE SENSOR
Type of Device
IMPLANTABLE GLUCOSE MONITORING SYSTEM, SENSOR
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key19009336
MDR Text Key338981049
Report Number3009862700-2024-00316
Device Sequence Number1
Product Code QCD
UDI-Device Identifier00817491023360
UDI-Public817491023360
Combination Product (y/n)Y
Reporter Country CodeSP
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 03/31/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date03/08/2022
Device Model Number101967-750
Device Catalogue NumberFG-4400-50-302
Device Lot NumberWP08438
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/14/2022
Initial Date FDA Received03/31/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured03/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-